This strategy not only eliminated intratumoral Fusobacterium nucleatum but also synergized with PD-L1 blockade, thereby serving as an effective combination to treat cancer by employing both ICIs and direct targeting of the bacteria for a more effective response. This evidence concerns the gene CD274 and cancer.